First Time Loading...

M1 Kliniken AG
XETRA:M12

Watchlist Manager
M1 Kliniken AG Logo
M1 Kliniken AG
XETRA:M12
Watchlist
Price: 15.3 EUR 11.68% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one M12 stock under the Base Case scenario is 14.56 EUR. Compared to the current market price of 15.3 EUR, M1 Kliniken AG is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

M12 Relative Value
Base Case
14.56 EUR
Overvaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
42
vs Industry
68
Median 3Y
0.5
Median 5Y
0.7
Industry
2.4
Forward
1
More Details
47.3
P/E
P/E
Price to Earnings
47.3
vs History
0
vs Industry
10
Median 3Y
25
Median 5Y
28.2
Industry
23.2
Forward
37.1
More Details
23.2
P/OCF
P/OCF
Price to OCF
23.2
vs History
23
vs Industry
18
Median 3Y
12.1
Median 5Y
12.1
Industry
15.5
More Details
51.1
P/FCFE
P/FCFE
Price to FCFE
51.1
vs History
14
vs Industry
12
Median 3Y
28.2
Median 5Y
23.4
Industry
23.5
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
46
vs Industry
43
Median 3Y
1.5
Median 5Y
1.9
Industry
2.2
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
44
vs Industry
71
Median 3Y
0.4
Median 5Y
0.6
Industry
2.5
Forward
0.8
More Details
5.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.2
vs History
39
vs Industry
43
Median 3Y
2.2
Median 5Y
3.6
Industry
5.2
More Details
14.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.8
vs History
44
vs Industry
25
Median 3Y
7.2
Median 5Y
10.3
Industry
12.5
Forward
12
More Details
21.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.6
vs History
42
vs Industry
23
Median 3Y
10.9
Median 5Y
15.7
Industry
17.2
Forward
17
More Details
20.3
EV/OCF
EV/OCF
Enterprise Value to OCF
20.3
vs History
25
vs Industry
23
Median 3Y
9.2
Median 5Y
9.2
Industry
15.1
More Details
22.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.9
vs History
15
vs Industry
22
Median 3Y
10.4
Median 5Y
6.8
Industry
19.7
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
34
vs Industry
38
Median 3Y
0.9
Median 5Y
1.2
Industry
2
More Details

Multiples Across Competitors

M12 Competitors Multiples
M1 Kliniken AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
M1 Kliniken AG
XETRA:M12
300.5m EUR 1 47.3 14.8 21.6
US
HCA Healthcare Inc
NYSE:HCA
81.7B USD 1.2 14.9 9.1 12.1
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
109.6B SAR 11.5 53.6 46.5 53.5
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
119.3B CNY 6.2 35.6 23.6 23.6
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
15.6B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
15.3B Zac 0 0 0 0
TH
Bangkok Dusit Medical Services PCL
SET:BDMS
456.9B THB 4.5 31.8 18.7 24.5
MY
IHH Healthcare Bhd
KLSE:IHH
55.7B MYR 2.7 18.9 10.8 14.7
US
Tenet Healthcare Corp
NYSE:THC
11.6B USD 0.6 19.5 6.9 9
US
Universal Health Services Inc
NYSE:UHS
11.3B USD 0.8 14 8.6 12.4
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
58.6B BRL 1.3 28.7 8.7 11.1

See Also

Summary
M12 intrinsic value, competitors valuation, and company profile.
DCF Valuation
M12 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
M12 stock valuation using valuation multiples.
Wall Street Estimates
M12 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
M12 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.